Applied therapeutics inc. (APLT)
Income statement / Yearly
Dec'19Dec'18
OPERATING EXPENSES:
Research and development

32,350

11,471

General and administrative

13,232

2,047

Total operating expenses

45,582

13,518

LOSS FROM OPERATIONS

-45,582

-13,518

OTHER INCOME (EXPENSE), NET:
Interest income (expense), net

93

-1,642

Loss on extinguishment of debt

-

-221

Other income (expense)

-24

-1,140

Total other income (expense), net

69

-3,003

Net loss

-45,513

-16,521

Net loss attributable to common stockholders—basic

-45,513

-16,521

Net loss attributable to common stockholders— diluted

-45,513

-16,521

Net loss per share attributable to common stockholders—basic and diluted

-3.55

-3.01

Weighted-average common stock outstanding—basic and diluted

12,831

5,483